Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Letter-Writing Add-On to Brief Motivational Intervention for Alcohol Use

4 de noviembre de 2026 actualizado por: Emily Grekin, Wayne State University

Enhancing Brief Motivational Interventions for Alcohol Use With Self-Determination Theory: A Pilot Letter-Writing Add-On

The goal of this pilot clinical trial is to learn whether adding a brief letter-writing exercise, grounded in Self-Determination Theory (SDT), to a brief motivational intervention (BMI) for alcohol use is feasible and acceptable, and to obtain preliminary estimates of its effects on psychological needs and motivation among adults who drink heavily and sometimes think about or wish they could cut back on their drinking.

The main questions it aims to answer are: (1) Is it feasible to integrate the letter-writing task into an SDT-informed BMI (recruitment, session completion, letter completion, retention)? (2) Do participants rate the letter-writing task as acceptable, appropriate, and feasible? (3) Compared with a neutral writing task, is the letter-writing task associated with higher perceived autonomy, competence, and relatedness, perceived competence for reducing drinking, and autonomous motivation?

Researchers will compare a BMI plus a neutral writing task with the same BMI plus the letter-writing task. Participants will complete a brief online screening survey; take part in a single 45-60-minute Zoom session that includes questionnaires, a 25-30-minute motivational interview, random assignment to either write an advice letter to another participant who has also thought about reducing their drinking or copy a neutral paragraph, and post-session questionnaires; and complete a 10-15-minute online follow-up survey about motivation, perceived competence, and alcohol use approximately one month later.

Descripción general del estudio

Tipo de estudio

Intervencionista

Inscripción (Estimado)

86

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Mariam A Souweidane
  • Número de teléfono: 734-707-8185
  • Correo electrónico: msouweidane@wayne.edu

Ubicaciones de estudio

    • Michigan
      • Detroit, Michigan, Estados Unidos, 48202
        • Wayne State University
        • Contacto:
          • Mariam A Souweidane, M.A.
          • Número de teléfono: 734-707-8185
          • Correo electrónico: msouweidane@wayne.edu

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Age 18 years or older
  • Resides in the United States
  • Meets the National Institute on Alcohol Abuse and Alcoholism heavy-drinking criteria in the past month
  • Answers Yes to "Do you sometimes think about reducing or wish you could reduce your alcohol use?"
  • Has internet access and a device capable of video conferencing via Zoom

Exclusion Criteria:

  • Failure to meet the inclusion criteria

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: BMI + Letter-Writing Condition

Participants will receive a brief, one-on-one, motivational intervention delivered via Zoom by a doctoral student in clinical psychology.

Immediately after the brief motivational intervention, participants write a brief advice letter to another study participant who has also thought about reducing their drinking but sometimes struggles with motivation. Prompts target autonomy, competence, and relatedness.

Comparador activo: BMI + Neutral Writing Condition

Participants will receive a brief, one-on-one, motivational intervention delivered via Zoom by a doctoral student in clinical psychology.

Immediately after the brief motivational intervention, participants copy a technical paragraph on office supply inventory management that matches the letter-writing task in length and duration.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Recruitment Feasibility: Enrollment Rate Among Eligible Individuals Who Accept an Invitation
Periodo de tiempo: From accepting the invitation to the Zoom session (up to 21 days)

Percentage of eligible people who accept an invitation and then enroll (attend the Zoom session, consent, and begin the baseline survey).

From accepting the invitation to the Zoom session (up to 21 days)
Session Completion Rate
Periodo de tiempo: Day 1

Percentage of enrolled participants who complete all parts of the Zoom session.

Day 1
Letter Completion Rate
Periodo de tiempo: Day 1

Percentage of participants assigned to letter writing who complete a letter during the session.

Day 1
Acceptability of the Letter-Writing Task (Acceptability of Intervention Measure)
Periodo de tiempo: Day 1

Mean of 4 Acceptability of Intervention Measure items, rated 1 (completely disagree) to 5 (completely agree); higher scores mean greater acceptability. Letter-writing participants only.

Day 1
Appropriateness of the Letter-Writing Task (Intervention Appropriateness Measure)
Periodo de tiempo: Day 1

Mean of 4 Intervention Appropriateness Measure items, rated 1 (completely disagree) to 5 (completely agree); higher scores mean greater appropriateness. Letter-writing participants only.

Day 1
Feasibility of the Letter-Writing Task (Feasibility of Intervention Measure)
Periodo de tiempo: Day 1

Mean of 4 Feasibility of Intervention Measure items, rated 1 (completely disagree) to 5 (completely agree); higher scores mean greater feasibility. Letter-writing participants only.

Day 1

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Retention at One-Month Follow-Up
Periodo de tiempo: Days 30 to 44 after the Zoom session

Proportion of randomized participants who complete the one-month follow-up survey within the 14-day response window (days 30-44 after the session), overall and by arm.

Days 30 to 44 after the Zoom session
State Autonomy for Drinking Decisions
Periodo de tiempo: Start of the Zoom session (baseline), immediately post-intervention (Day 1), and 1 month after the Zoom session

Single item rated 1 (not at all) to 7 (completely); higher scores mean greater autonomy.

Start of the Zoom session (baseline), immediately post-intervention (Day 1), and 1 month after the Zoom session
State Competence for Reducing Drinking
Periodo de tiempo: Start of the Zoom session (baseline), immediately post-intervention (Day 1), and 1 month after the Zoom session

Single item rated 1 (not capable at all) to 7 (extremely capable); higher scores mean greater competence.

Start of the Zoom session (baseline), immediately post-intervention (Day 1), and 1 month after the Zoom session
State Relatedness
Periodo de tiempo: Start of the Zoom session (baseline), immediately post-intervention (Day 1), and 1 month after the Zoom session

Single item rated 1 (not at all connected) to 7 (extremely connected); higher scores mean greater relatedness.

Start of the Zoom session (baseline), immediately post-intervention (Day 1), and 1 month after the Zoom session
Perceived Competence for Reducing Alcohol Use (Perceived Competence Scale)
Periodo de tiempo: Start of the Zoom session (baseline), immediately post-intervention (Day 1), and 1 month after the Zoom session

Mean of 4 items rated 1 (not at all true) to 7 (very true); higher scores mean greater perceived competence.

Start of the Zoom session (baseline), immediately post-intervention (Day 1), and 1 month after the Zoom session
Autonomous Motivation to Reduce Alcohol Use (Treatment Self-Regulation Questionnaire)
Periodo de tiempo: Start of the Zoom session (baseline) and 1 month after the Zoom session

Autonomous motivation score (mean of items rated 1 to 7); higher scores mean more autonomous motivation.

Start of the Zoom session (baseline) and 1 month after the Zoom session

Otras medidas de resultado

Medida de resultado
Medida Descripción
Periodo de tiempo
Heavy Drinking Days (Timeline Followback)
Periodo de tiempo: Start of the Zoom session (baseline) and 1 month after the Zoom session

Number of days in the past 30 with 5 or more (men) or 4 or more (women) standard drinks, measured with the Timeline Followback.

Start of the Zoom session (baseline) and 1 month after the Zoom session

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de noviembre de 2026

Finalización primaria (Estimado)

30 de marzo de 2027

Finalización del estudio (Estimado)

30 de abril de 2027

Fechas de registro del estudio

Enviado por primera vez

31 de octubre de 2026

Primero enviado que cumplió con los criterios de control de calidad

4 de noviembre de 2026

Publicado por primera vez (Actual)

9 de noviembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

9 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

4 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Términos MeSH relevantes adicionales

Otros números de identificación del estudio

  • IRB-25-12-8326

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir